Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Cooper Companies

This article was originally published in The Gray Sheet

Executive Summary

Board member Allan Rubenstein, MD, assumes chairmanship of the company following the resignation of Arthur Bass, the firm announced April 13. Rubenstein is founder and president of the MRI and CAT scan equipment provider MTV Imaging Services, Inc. and an associate professor and director of the Mt. Sinai Neurofibromatosis Research and Treatment Center in New York City. He has been a board member of Cooper since July 1992 and has chaired the board's management committee since October. Bass, who is taking a medical leave of absence, will remain on Cooper's board. Bass had assumed the post of acting chairman in May 1992 amidst allegations of mismanagement by Cooper's former co-chairmen ("The Gray Sheet" June 1, 1992, p. 32).

You may also be interested in...



QUOTED. 20 February 2020. Steven Raman.

Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.

Novartis Logs Into India With Digital Innovation Hub

Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.

Rx List Price Inflation Penalty Endorsed By US HHS Secretary

Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.

UsernamePublicRestriction

Register

MT000515

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel